Goldman Sachs analysts removed Baxter (BAX) from the firm’s US Conviction List as part of its monthly update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter International Reports Steady Q2 2025 Growth
- Baxter International’s Mixed Earnings Call Highlights Growth and Challenges
- Baxter downgraded to Neutral from Buy at Goldman Sachs
- Baxter cut to Neutral at Goldman Sachs after earnings miss, guidance cut
- Cautious Outlook for Baxter International Amid Weaker MPT Performance and Revised Growth Expectations